ArticleClinical pharmacology in drug development2021

Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN-812 (Viloxazine Extended-Release) Pharmacokinetics in Healthy Adults.

Zhao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.